Found 1 clinical trials
A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor)
The objectives of this study are to evaluate the safety and efficacy of Zimura intravitreal administration in patients with geographic atrophy secondary to age-related macular degeneration (AMD)
age-related macular degeneration
maculopathy
complement c5
geographic atrophy
atrophy
- 0 views
- 16 Feb, 2024
- 23 locations